Holdings
Biotechnology Fund
As of Jun 30, 2026, Biotechnology Fund reported 67 positions worth US$13.2M. Largest: Abbvie Inc., Amgen Inc. and Gilead Sciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abbvie Inc. | 4,369 | US$1.1M | +708 | Jun 30, 2026 |
| Amgen Inc. | 1,876 | US$679K | +274 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 4,786 | US$605K | +956 | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 1,170 | US$581K | +204 | Jun 30, 2026 |
| Regeneron Pharmaceuticals, Inc. | 633 | US$395K | +137 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 1,781 | US$334K | −90 | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 1,055 | US$318K | +207 | Jun 30, 2026 |
| Beone Medicines Ltd. Class A | 1,026 | US$292K | +197 | Jun 30, 2026 |
| Moderna, Inc. | 4,130 | US$289K | +637 | Jun 30, 2026 |
| Biogen Inc. | 1,325 | US$286K | +145 | Jun 30, 2026 |